Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Perinatol ; 44(7): 1035-1041, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38480787

RESUMO

BACKGROUND AND OBJECTIVE: Glucose-6-phosphate dehydrogenase deficiency (G6PDD) being highly prevalent in the Middle East, the primary objective was to estimate the incidence of neonatal jaundice among G6PD-deficient neonates and to explore its association with various risk factors. METHODS: This retrospective cohort study includes 7 years data of neonates diagnosed with G6PDD between 1st January 2015, and 30 September 2022, from Al Wakra Hospital, HMC Qatar. RESULTS: Among the 40,305 total births, 1013 had G6PDD with an incidence of 2.51%. Of all the G6PDD babies, 24.6% (249/1013) received phototherapy and three babies required exchange transfusion. Statistically significant associations were noted between the need for phototherapy and gestational age, gestational age groups, birth weight, and birth weight groups, but logistic regression analysis showed significant association for phototherapy only with the gestational age group. CONCLUSION: Universal screening and proper follow-up is essential for G6PDD as it plays crucial role in neonatal jaundice.


Assuntos
Idade Gestacional , Deficiência de Glucosefosfato Desidrogenase , Hiperbilirrubinemia Neonatal , Fototerapia , Humanos , Deficiência de Glucosefosfato Desidrogenase/epidemiologia , Deficiência de Glucosefosfato Desidrogenase/complicações , Estudos Retrospectivos , Recém-Nascido , Feminino , Masculino , Hiperbilirrubinemia Neonatal/epidemiologia , Hiperbilirrubinemia Neonatal/terapia , Catar/epidemiologia , Fatores de Risco , Incidência , Icterícia Neonatal/epidemiologia , Icterícia Neonatal/terapia , Peso ao Nascer , Modelos Logísticos , Transfusão Total
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...